Recognizing hypoglycemia in children through automated adverse-event detection

Mindy J Dickerman1, Brian R Jacobs, Hima Vinodrao

  • 1Division of Pediatric Critical Care Medicine, St Christopher's Hospital for Children, 3601 A St, Philadelphia, PA 19134, USA. mindy.dickerman@gmail.com

Pediatrics
|March 16, 2011
PubMed

Insights

Automated electronic health record (EHR) systems effectively detect hypoglycemia adverse events in hospitalized children. This method identified more events than voluntary reporting, especially in neonates and those on insulin.

Area of Science:

  • Pediatric Healthcare
  • Patient Safety
  • Health Informatics

Background:

  • Automated adverse-event detection using electronic health record (EHR) triggers is effective for identifying adverse events like hypoglycemia.
  • The actual incidence and harm of hypoglycemia-related adverse events in pediatric inpatients are not well understood.

Purpose of the Study:

  • To describe the utilization of an automated adverse-event detection system for identifying and classifying hypoglycemia-related adverse events in pediatric inpatients.
  • To assess the effectiveness of EHR-driven surveillance in detecting hypoglycemia in hospitalized children.

Main Methods:

  • A retrospective observational study analyzed all hypoglycemia triggers from an EHR-based surveillance system over one year at a children's hospital.
  • Triggers were reviewed to confirm true adverse events and deviations from the standard of care.
  • Clinical and demographic data were examined to identify at-risk patient groups.

Main Results:

  • The system generated 1254 hypoglycemia triggers, with 198 confirmed as adverse events (15.8% positive predictive value).
  • No hypoglycemia adverse events were detected through the hospital's voluntary incident reporting system.
  • Most adverse events occurred in the Neonatal Intensive Care Unit (NICU) (62.1%) and in patients receiving insulin therapy (77.8% hospital-wide).

Conclusions:

  • Hypoglycemia is prevalent in hospitalized children, particularly neonates and those treated with insulin.
  • An EHR-driven automated system successfully identified hypoglycemia in this pediatric population.
  • Automated adverse-event detection shows significant potential for enhancing patient safety programs in healthcare organizations using EHRs.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...